1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022) Authors: James, Nicholas D.; Clarke, Noel W.; Cook, Adrian; Ali, Adnan; Hoyle, Alex P.; Attard, Gerhardt; Brawley, Christopher D.; Chowdhury, Simon; Cross, William R.; Dearnaley, David P.; de Bono, Johann S.; Diaz‐Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J.; Langley, R... Journal: International journal of cancer Issue: Volume 151:Issue 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical approach of intratumoral heterogeneity in lung adenocarcinoma. Two clinical cases with changing somatic driver mutations. (2016) Authors: Saigi, Maria; Gilson, Clare; Rush, Hannah; Lal, Rohit Journal: Cancer treatment and research communications Issue: Number 9(2016) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. I105 Cancer immunotherapy with checkpoint inhibitors. (25th April 2018) Authors: Rush, Hannah Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunotherapy for prostate cancer: the next step?. Issue 2 (March 2016) Authors: Rush, Hannah; Gilson, Clare; Chowdhury, Simon Journal: Trends in urology & men's health Issue: Volume 7:Issue 2(2016) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience. (September 2020) Authors: Joharatnam-Hogan, Nalinie; Hochhauser, Daniel; Shiu, Kai-Keen; Rush, Hannah; Crolley, Valerie; Wilson, William; Sharma, Anand; Muhammad, Aun; Anwar, Muhammad; Vasdev, Nikhil; Goldstein, Robert; Kantser, Ganna; Saha, Aramita; Raja, Fharat; Bridgewater, John; Khan, Khurum Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Testing alternative schedules of adjuvant immune checkpoint blockers – The need for well-designed clinical trials. (January 2023) Authors: Bouche, Gauthier; Langley, Ruth; Rush, Hannah; Parmar, Mahesh; Gilbert, Duncan C. Journal: European journal of cancer Issue: Volume 178(2023) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗